PSEN1 and Alzheimer disease: Choi et al.’s approach, though elegant, suffered insofar as it required overexpression of fAD-linked mutations—such overexpression is not reminiscent of in vivo AD pathogenesis, and an ideal model would develop AD pathology naturally.